These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected. Bonadonna P, Zanotti R, Pagani M, Bonifacio M, Scaffidi L, Olivieri E, Franchini M, Reccardini F, Costantino MT, Roncallo C, Mauro M, Boni E, Rizzini FL, Bilò MB, Marcarelli AR, Passalacqua G. J Allergy Clin Immunol Pract; 2018; 6(4):1368-1372. PubMed ID: 29258788 [Abstract] [Full Text] [Related]
23. Risk Factor Analysis of Anaphylactic Reactions in Patients With Systemic Mastocytosis. Gülen T, Ljung C, Nilsson G, Akin C. J Allergy Clin Immunol Pract; 2017; 5(5):1248-1255. PubMed ID: 28351784 [Abstract] [Full Text] [Related]
24. Low Frequency of IgE-Mediated Food Hypersensitivity in Mastocytosis. Jarkvist J, Brockow K, Gülen T. J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3093-3101. PubMed ID: 32534147 [Abstract] [Full Text] [Related]
25. Fatal Anaphylaxis to Yellow Jacket Stings in Mastocytosis: Options for Identification and Treatment of At-Risk Patients. Vos BJPR, van Anrooij B, van Doormaal JJ, Dubois AEJ, Oude Elberink JNG. J Allergy Clin Immunol Pract; 2017 Oct; 5(5):1264-1271. PubMed ID: 28499778 [Abstract] [Full Text] [Related]
31. Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis? Matito A, Carter M. Curr Allergy Asthma Rep; 2015 May; 15(5):22. PubMed ID: 26139333 [Abstract] [Full Text] [Related]
33. Hymenoptera-induced anaphylaxis: is it a mast cell driven hematological disorder? Brockow K, Akin C. Curr Opin Allergy Clin Immunol; 2017 Oct; 17(5):356-362. PubMed ID: 28796123 [Abstract] [Full Text] [Related]
34. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Schwartz LB. Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288 [Abstract] [Full Text] [Related]
35. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome. Sonneck K, Florian S, Müllauer L, Wimazal F, Födinger M, Sperr WR, Valent P. Int Arch Allergy Immunol; 2007 Aug; 142(2):158-64. PubMed ID: 17057414 [Abstract] [Full Text] [Related]
36. Epidemiology, prognosis, and risk factors in mastocytosis. Brockow K. Immunol Allergy Clin North Am; 2014 May; 34(2):283-95. PubMed ID: 24745674 [Abstract] [Full Text] [Related]
37. Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels. Černiauskienė M, Bagdonaitė L, Karčiauskaitė D, Kvedarienė V. Med Sci Monit; 2022 Dec 14; 28():e937990. PubMed ID: 36514263 [Abstract] [Full Text] [Related]
38. Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre. Hermans MAW, Rietveld MJA, van Laar JAM, Dalm VASH, Verburg M, Pasmans SGMA, Gerth van Wijk R, van Hagen PM, van Daele PLA. Eur J Intern Med; 2016 May 14; 30():25-30. PubMed ID: 26809706 [Abstract] [Full Text] [Related]
39. Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly. Guenova E, Volz T, Eichner M, Hoetzenecker W, Caroli U, Griesinger G, Burow G, Mitev V, Biedermann T. Allergy; 2010 Jul 14; 65(7):919-23. PubMed ID: 20121769 [Abstract] [Full Text] [Related]